CVS (CVS) Offering Possible 28.87% Return Over the Next 24 Calendar Days

CVS's most recent trend suggests a bullish bias. One trading opportunity on CVS is a Bull Put Spread using a strike $74.50 short put and a strike $69.50 long put offers a potential 28.87% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $74.50 by expiration. The full premium credit of $1.12 would be kept by the premium seller. The risk of $3.88 would be incurred if the stock dropped below the $69.50 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for CVS is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for CVS is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for CVS

5 Strong Value Stocks to Buy As Treasury Yields Rise
Fri, 22 Nov 2019 19:22:36 +0000
There has been a lot of chatter recently about momentum stocks versus value stocks, thanks to a huge pivot that started in September. Specifically, investors are asking two questions — why did this pivot happen, and will it continue?In short, it's happening all because of the 10-year U.S. Treasury yield, and it will persist for the foreseeable future.The logic is simple. Lower yields support momentum stock valuations by decreasing the discount rate on future profits, and thereby increasing the net present value of future profits. Theoretically, this should help all stocks. But, momentum stocks derive more value from future profits than value stocks, so lower yields disproportionally benefit momentum stocks. Thus, when yields move lower, momentum stocks outperform. When yields go higher, momentum stocks underperform.InvestorPlace – Stock Market News, Stock Advice & Trading TipsThe data is also simple. From January to May 2019, the 10-year Treasury yield was largely range-bound between 2.5% and 2.7%. During that stretch, the the iShares Momentum Factor ETF (BATS:MTUM) and the iShares Value Factor ETF (BATS:VLUE) both returned about 13%-14%.From May to September 2019, however, the 10-year Treasury yield plunged from 2.5% to 1.5%. During that stretch, MTUM rose 6%. VLUE dropped 4%. Then, from September to November 2019, the 10-year Treasury yield rebounded to 2%, the Momentum Factors ETF fell flat, and the Value Factors ETF rose 11%. * 7 Companies Using Artificial Intelligence to Outperform the Market In the momentum versus value debate, it's all about yields. Thanks to an improving economic outlook, easing geopolitical tensions and a Federal Reserve that seems to be done with this rate-cut cycle, it appears that yields will keep rising for the foreseeable future. As they do, value stocks should continue to work.With that in mind, let's take a look a five strong value stocks that are worth buying as yields move higher. Strong Value Stocks to Buy: Intel (INTC)Source: JHVEPhoto / Shutterstock.com Percent Return Since September: 22%First on this list of strong value stocks to buy as yields move higher is global semiconductor giant Intel (NASDAQ:INTC).The bull thesis on INTC is simple. This is a value stock trading at a very reasonable 12.3-times forward earnings multiple, with a respectable 2.2% yield. Those are deep value characteristics, so as yields move higher and provide a boost to the whole value category, INTC stock should benefit from that boost.At the same time, thanks to easing global geopolitical tensions, economic activity is starting to pick back up. This is especially true in the semiconductor space, which has been hit hard in 2019 but has shown signs of bottoming and reversing course over the past few months. That's great news for Intel, whose data-centric business has been hit hard by slowing semiconductor demand over the past few quarters. But, much like the broader semiconductor space, Intel's data-centric business rebounded in a big way last quarter. That has sparked a 22% rally in INTC stock since early September.History says this is more than head-fake. Usually, if demand rebounds for several months following a multi-month streak of declines, it is the beginning of a big rebound in the semiconductor space. That's exactly what we have today. Thus, over the next few quarters, semiconductor demand should continue to bounce back, and so will Intel's data-centric business and INTC stock. General Electric (GE)Source: Jonathan Weiss / Shutterstock.com Percent Return Since September: 40%Next, we have beaten-up global industrial giant General Electric (NYSE:GE), which appears to be in the first few innings of staging a big comeback.GE stock is up 40% since early September. That's the biggest and most convincing rally this stock has staged in recent memory. Is it for real? Will the strength last?Yes and yes, because this recovery is supported by internal and external improvements which should persist. On the internal front, management continues to do everything right to get GE back on track. The company is paying off debt and reducing leverage on the balance sheet, divesting non-core businesses and simplifying the business model, and cutting costs where necessary to improve profitability. Management has said that they will continue to do all these things until profit trends improve in a big way. * 10 Cheap Stocks to Buy Under $10 Meanwhile, on the external front, easing trade tensions are providing a lift to corporate confidence levels around the globe. This lift in confidence should provide a boost to presently depressed capital spending trends. As those spending trends rebound, GE's numbers should improve, since this company is built on the back of industrial capital spending. At the same time, yields are moving higher, and that will help push this still relatively cheap stock higher. CVS (CVS)Source: QualityHD / Shutterstock.com Percent Return Since September: 23%Specialty pharmacy retailer CVS (NYSE:CVS) has regained its groove over the past few months and should stay on a winning path for the next few months, too.CVS stock is a value stock. At 10.6-times forward earnings with a 2.7% yield, this is the exact type of low-multiple, big-yield stock that investors think of when they think of value stocks. Thus, as value stocks continue to work thanks to rising yields, CVS stock should continue to work, too.Meanwhile, the fundamentals here are also improving. For a long time, this was just another stagnant, non-innovative pharmacy retailer with sluggish traffic, sales and profit trends. But, CVS is finally starting to innovate across multiple verticals, including rolling out localized healthcare HealthHUB locations. This innovation is powering a rebound in the company's sluggish traffic, sales and profit trends. So long as this rebound persists, investors will continue to push CVS stock higher against a favorable value stock backdrop.A favorable backdrop and favorable fundamental improvements should continue to push CVS stock higher. AT&T (T)Source: Jonathan Weiss / Shutterstock.com Percent Return Since September: 7%Often considered the king of deep value stocks, telecom giant AT&T (NYSE:T) should naturally be a winner as yields rise and value stocks move higher.There are two pieces to the bull thesis here. First, at almost 11-times forward earnings and with a 5%-plus dividend yield, AT&T stock is a prototypical deep value stock with a small multiple and a big yield. Those stocks tend to do well when yields move higher. AT&T stock is no exception. It's up 7% since yields started powering higher in early September. This strength should persist so long as yields keep grinding higher.Second, AT&T's fundamentals are set to meaningfully improve in 2020. For the past several years, AT&T has been plagued by cord-cutting trends in its video business. This has weighed on revenues and profits, and ultimately kept T stock stuck in neutral from 2015 through 2018. But, AT&T is set to launch a new streaming service in 2020, HBO Max, and this new streaming service should help the company offset its cord-cutting problem with streaming subscriber adds. * 9 Tantalizing Dividend Stocks for 2020 This should provide a nice boost for T stock. Just look at what happened to Disney (NYSE:DIS). This, too, is a company which has been mired in cord-cutting headwinds over the past few years. But, Disney launched a new streaming service in 2019, and early success of that streaming service has pushed DIS stock 35% higher year-to-date to all-time highs.The same could happen to AT&T stock in 2020. Skechers (SKX)Source: ThamKC / Shutterstock.com Percent Return Since September: 25%Last, but not least, on this list of strong value stocks to buy as yields rise is athletic apparel maker Skechers (NYSE:SKX).For all intents and purposes, Skechers is a growth company. Just look at the numbers. Constant-currency revenues rose 17.2% last quarter, paced by a 25.7% gain in the international business. Comparable-store sales rose 7.7% in the quarter. Gross and operating margins expanded. And, last quarter wasn't an anomaly. Since the start of 2018, Skechers' average constant-currency revenue growth rate has been above 12%. The international business has averaged about 20% growth, comps have averaged about 4% and margins have consistently powered higher.In other words, the numbers says Skechers is a growth company. But, SKX stock doesn't trade like a growth stock. It trades like a value stock.The forward earnings multiple on SKX stock? Just 15.6. That's below the apparel sector's average forward earnings multiple of 19, the consumer discretionary sector's average forward multiple of 22 and the footwear sector's average forward multiple of 28. It's also well below where both peers Under Armour (NYSE:UA, NYSE:UAA) and Nike (NYSE:NKE) trade, and yet, Skechers is growing at a faster pace than both of those companies.Broadly, then, Skechers is a growth company trading at a value stock valuation. That discrepancy implies a favorable risk-reward profile for bulls, especially in an environment where value stocks are set to move higher.As of this writing, Luke Lango was long INTC, GE, CVS, T, DIS, SKX and NKE. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Companies Using Artificial Intelligence to Outperform the Market * 7 Earnings Reports to Watch Next Week * 6 Retail Stocks Dropping Hard Ahead of Black Friday The post 5 Strong Value Stocks to Buy As Treasury Yields Rise appeared first on InvestorPlace.

3 Healthcare Stocks to Counter Tech Encroachment
Fri, 22 Nov 2019 13:00:01 +0000
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.

AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Subsidiaries
Thu, 21 Nov 2019 21:18:00 +0000
AM Best has affirmed the Financial Strength Rating of A and the Long-Term Issuer Credit Ratings of “a” of Aetna Life Insurance Company and the other operating entities of Aetna Inc.

12 Dividend Stocks to Build a Monthly Income Calendar
Thu, 21 Nov 2019 19:44:05 +0000
Most U.S. companies that pay dividends do it quarterly, or once every 90 days or so (foreign firms usually pay but once or twice a year). If your income stocks are on the same schedule, your payments will come much less regularly than, say, your relentless gas and electric bills.That's why many retirees and other dividend fans try to arrange matters so the income arrives more frequently. You can easily assemble a set of excellent dividend stocks with staggered pay dates. That's the idea of our Dividend-a-Month portfolio, assembled by the editors of Kiplinger's Investing for Income: cash every month, without interruption. You can play the calendar without dabbling in questionable stocks or worrying about the reliability of dividends.As a practical matter, note two key dates for dividend stocks. One is the "record date," the deadline to be a shareholder so you get the next payment. The record date is usually three to six weeks before the "payment date," which is when the dollars should appear in your brokerage account. We're using the actual arrival of the payment to match companies with their months. SEE ALSO: 14 High-Yield Dividend Stocks to Buy for the 4% Rule

The success of Medicare Advantage makes it a better policy choice than ‘Medicare for All’
Thu, 21 Nov 2019 14:23:00 +0000
It’s hunting season for health insurers, commonly referred to as “open enrollment.” People over 65 who turn on their TV or open their mailbox from late October through November can’t escape advertisements from private health insurers offering so-called Medicare Advantage plans on behalf of the federal government. The process may be mildly annoying, but it is a sign of vitality in a public-private partnership that is delivering high-quality health care at comparatively low cost. Over one-third of all Medicare beneficiaries now enroll in these plans.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.